Paul A. Grayson - Aug 18, 2023 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role: Director
Signature: /s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol: SKYE
Transactions as of: Aug 18, 2023
Transactions value $: $0
Form type: 3
Date filed: 8/22/2023, 05:19 PM
Next filing: Aug 29, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney.